Citi Maintains Medtronic(MDT.US) With Hold Rating, Announces Target Price $92

花旗维持美敦力(MDT.US)持有评级，目标价92美元

moomoo资讯 · 10/01 06:31 · 评级/大行评级

Citi analyst Joanne Wuensch maintains $Medtronic (MDT.US)$ with a hold rating, and sets the target price at $92.

According to TipRanks data, the analyst has a success rate of 64.0% and a total average return of 6.4% over the past year.

AnalystRecentRatingAutoNews_201438_20241001_0fa7dd684e0b6f105a29643696177d66883859ec_1727872220849401_mm_en

Furthermore, according to the comprehensive report, the opinions of $Medtronic (MDT.US)$'s main analysts recently are as follows:

The firm questions whether the recent upswing in medical technology stocks is sustainable as the industry approaches the third-quarter financial reports. Adopting a cautious stance, analysts note that the third quarter typically presents challenges within the medical technology sector, with particular focus on the 2025 outlook and discussions regarding projections for the upcoming year potentially influencing stock movement in the short term.
Utilization in MedTech continues to show positive trends going into the third quarter, and the outlook for capital expenditures into the following year remains robust. In the segment of life science tools, expectations are set for bioprocess trends to improve in the latter half of the year. However, discussions persist regarding the future of instrument demand and the impact of potential stimulus measures in China, particularly considering the recent performance of stocks in this sector. Medtronic, among other selected companies, is identified for potential outperformance, with a positive outlook sustained for Exact Sciences as the third-quarter financial results approach.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

花旗分析师Joanne Wuensch维持$美敦力 (MDT.US)$持有评级，目标价92美元。

根据TipRanks数据显示，该分析师近一年总胜率为64.0%，总平均回报率为6.4%。

AnalystRecentRatingAutoNews_201438_20241001_0fa7dd684e0b6f105a29643696177d66883859ec_1727872220849401_mm_sc

此外，综合报道，$美敦力 (MDT.US)$近期主要分析师观点如下：

该公司质疑，随着该行业接近第三季度财务报告，近期医疗科技股的上涨是否可持续。分析师采取谨慎的立场指出，第三季度通常会给医疗技术行业带来挑战，特别关注2025年的展望，以及关于来年预测的讨论，可能会在短期内影响股票走势。
进入第三季度，医疗科技的利用率继续显示出积极的趋势，下一年的资本支出前景仍然强劲。在生命科学工具领域，预计下半年生物工艺趋势将有所改善。但是，关于未来工具需求和中国潜在刺激措施影响的讨论仍在继续，特别是考虑到该行业股票的近期表现。美敦力和其他入选公司被认为有可能跑赢大盘，随着第三季度财务业绩的临近，Exact Sciences的前景保持乐观。

提示:

TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。

TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。

分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。

总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

Citi Maintains Medtronic(MDT.US) With Hold Rating, Announces Target Price $92

Citi Maintains Medtronic(MDT.US) With Hold Rating, Announces Target Price $92

风险及免责提示

声明